Related Experiment Video
Updated: Jan 20, 2026
04:20
Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
6.2K
Exercise Intolerance in Heart Failure: Central Role for the Pulmonary System
Sophie Lalande1, Troy J Cross, Manda L Keller-Ross2
1Department of Kinesiology and Heath Education, The University of Texas at Austin, Austin, TX.
Exercise and Sport Sciences Reviews
|August 28, 2019
Summary
Pulmonary abnormalities significantly worsen breathlessness and exercise limits in chronic heart failure patients. Targeting these lung issues may improve exercise tolerance and quality of life.
Area of Science:
- Cardiology
- Pulmonology
- Exercise Physiology
Background:
- Chronic heart failure (CHF) is frequently associated with reduced exercise tolerance.
- Exertional dyspnea is a primary symptom limiting physical activity in CHF patients.
- The contribution of pulmonary factors to these limitations is not fully elucidated.
Purpose of the Study:
- To investigate the role of pulmonary system abnormalities in exertional dyspnea and exercise intolerance in chronic heart failure.
- To explore the potential of pulmonary-focused interventions for improving exercise capacity in CHF.
Main Methods:
- This study proposes a conceptual framework linking pulmonary dysfunction to heart failure symptoms.
- It reviews existing literature on pulmonary manifestations in CHF.
- It hypothesizes the impact of pulmonary interventions on exercise tolerance.
Main Results:
- Pulmonary system abnormalities are proposed as a significant contributor to exertional dyspnea.
- These pulmonary issues are linked to reduced exercise tolerance in patients with chronic heart failure.
- The findings suggest a strong correlation between pulmonary health and functional capacity in CHF.
Conclusions:
- Abnormalities in the pulmonary system play a critical role in the exercise limitations experienced by chronic heart failure patients.
- Interventions targeting the pulmonary manifestations of heart failure hold promise for enhancing exercise tolerance.
- Addressing pulmonary aspects could be a key strategy for improving outcomes in CHF.
More Related Videos
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
3.4K
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
1.9K
Related Concept Videos
01:29Heart Failure II: Pathophysiology
768
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
768
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:27Heart Failure I: Introduction
720
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
720
01:22Heart Failure VI: Adjunct Therapies
273
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
273
01:22Heart Failure Drugs: Diuretics
821
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
821
01:30Heart Failure V: Medical Management
225
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
225